In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models
- 1 February 2006
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 33 (2) , 227-237
- https://doi.org/10.1016/j.nucmedbio.2005.10.011
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agentsNuclear Medicine and Biology, 2004
- Targeting of gelatinase activity with a radiolabeled cyclic HWGF peptideNuclear Medicine and Biology, 2004
- Comparative in Vivo Stability of Copper-64-Labeled Cross-Bridged and Conventional Tetraazamacrocyclic ComplexesJournal of Medicinal Chemistry, 2004
- Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targetsInternational Journal of Cancer, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- MicroPET: a high resolution PET scanner for imaging small animalsIEEE Transactions on Nuclear Science, 1997
- Efficient production of high specific activity 64Cu using a biomedical cyclotronNuclear Medicine and Biology, 1997
- Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological mediaFEBS Letters, 1996
- The application of receptor theory to receptor-binding and enzyme-binding oncologic radiopharmaceuticalsNuclear Medicine and Biology, 1994
- Type IV collagenases in invasive tumorsBreast Cancer Research and Treatment, 1993